Colossal biosciences, colossal decacorn, Dallas genetic engineering pioneer Colossal Biosciences hits $10.2B valuation with its latest $200M Series C funding, leading breakthrough conservation tech and species revival research from its Texas headquarters.
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/fe8e3085-d045-45b8-b774-ebde2c284565)